Breast cancer is the second leading cause of cancer death and the leading cause of premature death of women in the United States (US). It was estimated that 231,840 women were expected to develop breast cancer in the US in 2015 and approximately 40,290 women were estimated to die of the disease. Even though most breast cancers are sporadic, 5-10% of women are at an increased risk for developing breast cancer due to a hereditary risk. Too few healthcare providers are identifying women with family histories suggestive of hereditary cancer syndromes. An efficient way to identify high risk women in the primary care setting is through an easy to understand, self-administered family history risk assessment tool. The Pedigree Assessment Tool (PAT)...
BACKGROUND: Primary care is expected to play a significant role in the management of patients with g...
Currently there is much debate regarding the ability of mathematical models incorporating epidemiolo...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
The recognition of an inherited component to breast cancer has led to an increase in demand for info...
Identification of risk for the hereditary breast and ovarian cancer syndrome (HBOC) is important, as...
The detection of deleterious germline mutations in BRCA1 and BRCA2 considerably influences the clini...
Background. Assessing a genetic risk for developing breast cancer is not an easy task for a GP. Curr...
Background. Assessing a genetic risk for developing breast cancer is not an easy task for a GP. Curr...
Background: Breast cancer is a significant public health problem worldwide and the development of to...
Women with a family history of breast cancer dominate referrals for cancer genetic risk counselling ...
Objective: To increase identification and genetic referral rates for women at risk of Hereditary Bre...
Pilot study to evaluate whether the use of a standardized questionnaire to document family history o...
Background: Primary care is expected to play a significant role in the management of patients with g...
Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ov...
Background: With the identification of genes predisposing to hereditary breast cancer, the accurate ...
BACKGROUND: Primary care is expected to play a significant role in the management of patients with g...
Currently there is much debate regarding the ability of mathematical models incorporating epidemiolo...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
The recognition of an inherited component to breast cancer has led to an increase in demand for info...
Identification of risk for the hereditary breast and ovarian cancer syndrome (HBOC) is important, as...
The detection of deleterious germline mutations in BRCA1 and BRCA2 considerably influences the clini...
Background. Assessing a genetic risk for developing breast cancer is not an easy task for a GP. Curr...
Background. Assessing a genetic risk for developing breast cancer is not an easy task for a GP. Curr...
Background: Breast cancer is a significant public health problem worldwide and the development of to...
Women with a family history of breast cancer dominate referrals for cancer genetic risk counselling ...
Objective: To increase identification and genetic referral rates for women at risk of Hereditary Bre...
Pilot study to evaluate whether the use of a standardized questionnaire to document family history o...
Background: Primary care is expected to play a significant role in the management of patients with g...
Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ov...
Background: With the identification of genes predisposing to hereditary breast cancer, the accurate ...
BACKGROUND: Primary care is expected to play a significant role in the management of patients with g...
Currently there is much debate regarding the ability of mathematical models incorporating epidemiolo...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...